BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14905420)

  • 1. Clinical observations on the use of triethylenemelamine.
    BAYRD ED; STICKNEY JM; HALL BE; WATKINS CH
    Cancer; 1952 Mar; 5(2):336-43. PubMed ID: 14905420
    [No Abstract]   [Full Text] [Related]  

  • 2. Triethylene melamine in clinical cancer chemotherapy.
    GELLHORN A; KLIGERMAN MM; JAFFE I
    Am J Med; 1952 Oct; 13(4):428-31. PubMed ID: 12985600
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of triethylene melamine in the treatment of neoplasms].
    DI PIETRO S
    Minerva Med; 1953 Mar; 44(19):585-92. PubMed ID: 13071885
    [No Abstract]   [Full Text] [Related]  

  • 4. [Triethylene melamine, a new agent in the treatment of cancer].
    ROCCHIETTA S
    Boll Chim Farm; 1952 Oct; 91(10):407-9. PubMed ID: 13032250
    [No Abstract]   [Full Text] [Related]  

  • 5. [Triethylene melamine: new chemotherapeutic agent for tumors].
    ROETTEGLIA E
    Minerva Farm; 1953 May; 2(5):177. PubMed ID: 13086708
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral triethylene melamine therapy in human neoplastic disease.
    BLACKBURN EK; KING GM
    J Fac Radiol; 1954 Oct; 6(2):96-103. PubMed ID: 24543599
    [No Abstract]   [Full Text] [Related]  

  • 7. [Triethylene melamine therapy of malignant granulomatosis and certain other malignant diseases].
    HANSEN PB; BICHEL J
    Nord Med; 1952 Jan; 47(2):58-61. PubMed ID: 14910945
    [No Abstract]   [Full Text] [Related]  

  • 8. The oral use of triethylene melamine; a compound with nitrogen mustard-like activity.
    KARNOFSKY DA; BURCHENAL JH; BERNSTEIN JL; SOUTHAM CM
    Acta Unio Int Contra Cancrum; 1953; 9(1):97-100. PubMed ID: 13057680
    [No Abstract]   [Full Text] [Related]  

  • 9. [30 Cases of hemoblastosis and 6 cases of neoplasms of various types treated with triethylenemelamine].
    STORTI E; MANZINI E
    G Ital Chemioter; 1954; 1(1):116-9. PubMed ID: 13191601
    [No Abstract]   [Full Text] [Related]  

  • 10. Triethylene melamine in human malignant disease; results with oral administration of enteric-coated tablets.
    PATERSON E; KUNKLER PB; WALPOLE AL
    Br Med J; 1953 Jan; 1(4801):59-64. PubMed ID: 12997844
    [No Abstract]   [Full Text] [Related]  

  • 11. Further observations on the use of triethylene melamine in neoplastic diseases.
    WRIGHT JC; PRIGOT A; WRIGHT LT; ARONS I
    AMA Arch Intern Med; 1952 Mar; 89(3):387-404. PubMed ID: 14902152
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with triethylene melamine (TEM) and triethylene thiophosphoramide (thioTEPA) in recurrent or metastatic solid tumors.
    SCHELL RF; HALL BE
    Surg Gynecol Obstet; 1958 Apr; 106(4):459-65. PubMed ID: 13529522
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immediate results of triethylene melamine therapy of neoplastic diseases].
    LENTI G; GAVOSTO F
    Minerva Med; 1953 Jan; 44(1-2):1-19. PubMed ID: 13054386
    [No Abstract]   [Full Text] [Related]  

  • 14. Urethane plus triethylene melamine therapy in human cancer cases.
    BLACK MM; SPEER FD
    N Y State J Med; 1954 May; 54(10):1477-80. PubMed ID: 13154643
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of malignant diseases with triethylene melamine].
    ROMEO ORBEGOZO JM
    Rev Clin Esp; 1953 Sep; 50(5):382-6. PubMed ID: 13134813
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of tri-ethylene melamine and of tri-ethylene phosphoramide in human neoplastic diseases.
    WRIGHT JC; PRIGOT A; LOGAN M; HILL LM
    Acta Unio Int Contra Cancrum; 1955; 11(2):220-57. PubMed ID: 13248731
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the treatment of malignant disease. V].
    KOYAMA Y; KONO M; TAKEMASA Y; HUKUDA R; AMAKI I
    Gan; 1956 Dec; 47(3-4):313-5. PubMed ID: 13415017
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of malignant tumors, especially with nitromin and TEM].
    KOYAMA Y; KUMATORI T; TAKEMASA Y
    Gan; 1953 Sep; 44(2-3):374-6. PubMed ID: 13128202
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations on the use of triethylene melamine in Hodgkin's disease.
    DE ANDINO AM; ROMERO C; RIVERA J; RODRIGUEZ-MOLINA R
    Bol Asoc Med P R; 1953 Apr; 45(4):107-18. PubMed ID: 13066528
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rational approach to therapy of cancer with haloalkylamines and with ethylenemelanines].
    ZHDANOV GL
    Biull Eksp Biol Med; 1955 Sep; 40(9):65-9. PubMed ID: 13276475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.